Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1996 Aug;55(8):494–496. doi: 10.1136/ard.55.8.494

The clinical utility of ANCA positivity.

J D Edgar
PMCID: PMC1010223  PMID: 8774174

Full text

PDF
494

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baslund B., Segelmark M., Wiik A., Szpirt W., Petersen J., Wieslander J. Screening for anti-neutrophil cytoplasmic antibodies (ANCA): is indirect immunofluorescence the method of choice? Clin Exp Immunol. 1995 Mar;99(3):486–492. doi: 10.1111/j.1365-2249.1995.tb05577.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blank M., Tomer Y., Stein M., Kopolovic J., Wiik A., Meroni P. L., Conforti G., Shoenfeld Y. Immunization with anti-neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration. Clin Exp Immunol. 1995 Oct;102(1):120–130. doi: 10.1111/j.1365-2249.1995.tb06645.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Coremans I. E., Hagen E. C., Daha M. R., van der Woude F. J., van der Voort E. A., Kleijburg-van der Keur C., Breedveld F. C. Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum. 1992 Dec;35(12):1466–1475. doi: 10.1002/art.1780351210. [DOI] [PubMed] [Google Scholar]
  4. Davenport A., Lock R. J., Wallington T. B., Feest T. G. Clinical significance of anti-neutrophil cytoplasm antibodies detected by a standardized indirect immunofluorescence assay. Q J Med. 1994 May;87(5):291–299. [PubMed] [Google Scholar]
  5. Davenport A., Lock R. J., Wallington T. Clinical significance of the serial measurement of autoantibodies to neutrophil cytoplasm using a standard indirect immunofluorescence test. Am J Nephrol. 1995;15(3):201–207. doi: 10.1159/000168833. [DOI] [PubMed] [Google Scholar]
  6. Davies D. J., Moran J. E., Niall J. F., Ryan G. B. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? 1982 Aug 28-Sep 4Br Med J (Clin Res Ed) 285(6342):606–606. doi: 10.1136/bmj.285.6342.606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Edgar J. D., McMillan S. A., Bruce I. N., Conlan S. K. An audit of ANCA in routine clinical practice. Postgrad Med J. 1995 Oct;71(840):605–612. doi: 10.1136/pgmj.71.840.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Edgar J. D., Rooney D. P., McNamee P., McNeill T. A. An association between ANCA positive renal disease and malignancy. Clin Nephrol. 1993 Jul;40(1):22–25. [PubMed] [Google Scholar]
  9. Efthimiou J., Spickett G., Lane D., Thompson A. Antineutrophil cytoplasmic antibodies, cystic fibrosis, and infection. Lancet. 1991 Apr 27;337(8748):1037–1038. doi: 10.1016/0140-6736(91)92694-w. [DOI] [PubMed] [Google Scholar]
  10. Egner W., Chapel H. M. Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides. Clin Exp Immunol. 1990 Nov;82(2):244–249. doi: 10.1111/j.1365-2249.1990.tb05434.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Esnault V. L., Ronda N., Jayne D. R., Lockwood C. M. Association of ANCA isotype and affinity with disease expression. J Autoimmun. 1993 Apr;6(2):197–205. doi: 10.1006/jaut.1993.1017. [DOI] [PubMed] [Google Scholar]
  12. Falk R. J., Terrell R. S., Charles L. A., Jennette J. C. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A. 1990 Jun;87(11):4115–4119. doi: 10.1073/pnas.87.11.4115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gross W. L., Schmitt W. H., Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol. 1993 Jan;91(1):1–12. doi: 10.1111/j.1365-2249.1993.tb03345.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hagen E. C. Development and standardization of solid-phase assays for the detection of antineutrophil cytoplasmic antibodies (ANCA) for clinical application: report of a large clinical evaluation study. Clin Exp Immunol. 1995 Jul;101 (Suppl 1):29–29. doi: 10.1111/j.1365-2249.1995.tb06160.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Jayne D. R., Gaskin G., Pusey C. D., Lockwood C. M. ANCA and predicting relapse in systemic vasculitis. QJM. 1995 Feb;88(2):127–133. [PubMed] [Google Scholar]
  16. Jennette J. C., Falk R. J. Antineutrophil cytoplasmic autoantibodies and associated diseases: a review. Am J Kidney Dis. 1990 Jun;15(6):517–529. doi: 10.1016/s0272-6386(12)80521-x. [DOI] [PubMed] [Google Scholar]
  17. Juby A., Johnston C., Davis P., Russell A. S. Antinuclear and antineutrophil cytoplasmic antibodies (ANCA) in the sera of patients with Felty's syndrome. Br J Rheumatol. 1992 Mar;31(3):185–188. doi: 10.1093/rheumatology/31.3.185. [DOI] [PubMed] [Google Scholar]
  18. Kerr G. S., Fleisher T. A., Hallahan C. W., Leavitt R. Y., Fauci A. S., Hoffman G. S. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum. 1993 Mar;36(3):365–371. doi: 10.1002/art.1780360312. [DOI] [PubMed] [Google Scholar]
  19. Leavitt R. Y., Fauci A. S., Bloch D. A., Michel B. A., Hunder G. G., Arend W. P., Calabrese L. H., Fries J. F., Lie J. T., Lightfoot R. W., Jr The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990 Aug;33(8):1101–1107. doi: 10.1002/art.1780330807. [DOI] [PubMed] [Google Scholar]
  20. Luqmani R. A., Bacon P. A., Beaman M., Scott D. G., Emery P., Lee S. J., Howie A. J., Richards N., Michael J., Adu D. Classical versus non-renal Wegener's granulomatosis. Q J Med. 1994 Mar;87(3):161–167. [PubMed] [Google Scholar]
  21. Mains B. Wegener's granulomatosis: false positive anti-neutrophil cytoplasmic antibody test. J Laryngol Otol. 1989 May;103(5):524–525. doi: 10.1017/s0022215100156774. [DOI] [PubMed] [Google Scholar]
  22. Mulder A. H., Heeringa P., Brouwer E., Limburg P. C., Kallenberg C. G. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a Fc gamma RII-dependent process. Clin Exp Immunol. 1994 Nov;98(2):270–278. doi: 10.1111/j.1365-2249.1994.tb06137.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Nash M. C., Shah V., Reader J. A., Dillon M. J. Anti-neutrophil cytoplasmic antibodies and anti-endothelial cell antibodies are not increased in Kawasaki disease. Br J Rheumatol. 1995 Sep;34(9):882–887. doi: 10.1093/rheumatology/34.9.882. [DOI] [PubMed] [Google Scholar]
  24. Porges A. J., Redecha P. B., Kimberly W. T., Csernok E., Gross W. L., Kimberly R. P. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. J Immunol. 1994 Aug 1;153(3):1271–1280. [PubMed] [Google Scholar]
  25. Ramírez G., Khamashta M. A., Hughes G. R. The ANCA test: its clinical relevance. Ann Rheum Dis. 1990 Oct;49(10):741–742. doi: 10.1136/ard.49.10.741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Rao J. K., Allen N. B., Feussner J. R., Weinberger M. A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis. Lancet. 1995 Oct 7;346(8980):926–931. doi: 10.1016/s0140-6736(95)91555-9. [DOI] [PubMed] [Google Scholar]
  27. Rose N. R., Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited) Immunol Today. 1993 Sep;14(9):426–430. doi: 10.1016/0167-5699(93)90244-F. [DOI] [PubMed] [Google Scholar]
  28. Rump J. A., Schölmerich J., Gross V., Roth M., Helfesrieder R., Rautmann A., Lüdemann J., Gross W. L., Peter H. H. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiology. 1990 Nov;181(4-5):406–413. doi: 10.1016/S0171-2985(11)80509-7. [DOI] [PubMed] [Google Scholar]
  29. Schnabel A., Csernok E., Isenberg D. A., Mrowka C., Gross W. L. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance. Arthritis Rheum. 1995 May;38(5):633–637. doi: 10.1002/art.1780380509. [DOI] [PubMed] [Google Scholar]
  30. Segelmark M., Baslund B., Wieslander J. Some patients with anti-myeloperoxidase autoantibodies have a C-ANCA pattern. Clin Exp Immunol. 1994 Jun;96(3):458–465. doi: 10.1111/j.1365-2249.1994.tb06051.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Spickett G. P., Broomhead V. Formalin fixation and patterns of antineutrophil cytoplasmic antibodies. J Clin Pathol. 1995 Jan;48(1):89–90. doi: 10.1136/jcp.48.1.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Targan S. R., Landers C., Vidrich A., Czaja A. J. High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology. 1995 Apr;108(4):1159–1166. doi: 10.1016/0016-5085(95)90215-5. [DOI] [PubMed] [Google Scholar]
  33. Tervaert J. W., Huitema M. G., Hené R. J., Sluiter W. J., The T. H., van der Hem G. K., Kallenberg C. G. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet. 1990 Sep 22;336(8717):709–711. doi: 10.1016/0140-6736(90)92205-v. [DOI] [PubMed] [Google Scholar]
  34. Vecchio T. J. Predictive value of a single diagnostic test in unselected populations. N Engl J Med. 1966 May 26;274(21):1171–1173. doi: 10.1056/NEJM196605262742104. [DOI] [PubMed] [Google Scholar]
  35. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS Suppl. 1989;6:12–13. [PubMed] [Google Scholar]
  36. van der Woude F. J., Rasmussen N., Lobatto S., Wiik A., Permin H., van Es L. A., van der Giessen M., van der Hem G. K., The T. H. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet. 1985 Feb 23;1(8426):425–429. doi: 10.1016/s0140-6736(85)91147-x. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES